Envestnet Asset Management Inc Pacira Bio Sciences, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$25.5 - $31.51 $52,377 - $64,721	-2,054 Reduced 4.75%	41,216 $1.18 Million
Q1 2024 May 13, 2024	BUY	$27.7 - $35.48 $203,373 - $260,494	7,342 Added 20.44%	43,270 $1.26 Million
Q4 2023 Feb 13, 2024	BUY	$26.32 - $34.31 $66,168 - $86,255	2,514 Added 7.52%	35,928 $1.21 Million
Q3 2023 Nov 13, 2023	SELL	$30.68 - $40.09 $23,899 - $31,230	-779 Reduced 2.28%	33,414 $1.03 Million
Q2 2023 Aug 04, 2023	SELL	$36.12 - $47.5 $19,974 - $26,267	-553 Reduced 1.59%	34,193 $1.37 Million
Q1 2023 May 11, 2023	BUY	$35.53 - $43.38 $469,067 - $572,702	13,202 Added 61.28%	34,746 $1.42 Million
Q4 2022 Feb 07, 2023	SELL	$38.19 - $57.45 $162,460 - $244,392	-4,254 Reduced 16.49%	21,544 $831,000
Q3 2022 Nov 10, 2022	SELL	$51.24 - $58.89 $6,353 - $7,302	-124 Reduced 0.48%	25,798 $1.37 Million
Q2 2022 Aug 03, 2022	SELL	$51.49 - $81.64 $51,078 - $80,986	-992 Reduced 3.69%	25,922 $1.51 Million
Q1 2022 May 04, 2022	BUY	$60.03 - $76.49 $91,005 - $115,958	1,516 Added 5.97%	26,914 $2.05 Million
Q4 2021 Feb 04, 2022	BUY	$47.97 - $62.21 $89,512 - $116,083	1,866 Added 7.93%	25,398 $1.53 Million
Q3 2021 Oct 07, 2021	BUY	$54.64 - $61.3 $328,222 - $368,229	6,007 Added 34.28%	23,532 $1.32 Million
Q2 2021 Aug 04, 2021	BUY	$59.18 - $69.99 $30,477 - $36,044	515 Added 3.03%	17,525 $1.06 Million
Q1 2021 May 04, 2021	BUY	$59.31 - $78.82 $195,782 - $260,184	3,301 Added 24.08%	17,010 $1.19 Million
Q4 2020 Feb 02, 2021	BUY	$50.47 - $66.26 $41,284 - $54,200	818 Added 6.35%	13,709 $820,000
Q3 2020 Oct 09, 2020	BUY	$51.97 - $63.0 $417,475 - $506,079	8,033 Added 165.36%	12,891 $775,000
Q2 2020 Jul 08, 2020	BUY	$30.8 - $52.47 $149,626 - $254,899	4,858 New	4,858 $255,000
Q1 2020 Apr 23, 2020	SELL	$28.4 - $50.7 $207,178 - $369,856	-7,295 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$36.31 - $46.83 $264,881 - $341,624	7,295 New	7,295 $330,000
Q3 2019 Oct 17, 2019	SELL	$35.66 - $44.99 $199,268 - $251,404	-5,588 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$36.57 - $47.97 $204,353 - $268,056	5,588 New	5,588 $243,000
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $41,620 - $65,884	-1,267 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$27.5 - $39.8 $2,447 - $3,542	-89 Reduced 6.56%	1,267 $41,000
Q1 2018 May 09, 2018	SELL	$29.98 - $46.35 $14,420 - $22,294	-481 Reduced 26.18%	1,356 $42,000
Q4 2017 Feb 20, 2018	SELL	$31.85 - $46.95 $2,293 - $3,380	-72 Reduced 3.77%	1,837 $83,000
Q3 2017 Nov 13, 2017	BUY	$35.7 - $39.5 $18,314 - $20,263	513 Added 36.75%	1,909 $72,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,396	1,396 $67,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account